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Autophagyandapoptosisare twoimportant andinterconnected stress-response mechanisms.However, the molecular interplay
between these two pathways is not fully understood. To study the fate and function of autophagic proteins at the onset of
apoptosis, we used a cellular model system in which autophagy precedes apoptosis. IL-3 depletion of Ba/F3 cells caused
caspase (casp)-mediated cleavage of Beclin-1 and PI3KC3, two crucial components of the autophagy-inducing complex. We
identiﬁed two casp cleavage sites in Beclin-1, TDVD
133 and DQLD
149, cleavage at which yields fragments lacking the autophagy-
inducing capacity. Noteworthy, the C-terminal fragment, Beclin-1-C, localized predominantly at the mitochondria and sensitized
the cells to apoptosis. Moreover, on isolated mitochondria, recombinant Beclin-1-C was able to induce the release of
proapoptotic factors. These ﬁndings point to a mechanism by which casp-dependent generation of Beclin-1-C creates an
amplifying loop enhancing apoptosis upon growth factor withdrawal.
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Under favorable conditions, cells maintain a balance between
synthesis, degradation and recycling of cellular components.
One key regulatory mechanism maintaining this balance
is autophagy, a catabolic process involving engulfment
of proteins, lipids and/or organelles by double-membrane
vesicles, the autophagosomes, and consequent breakdown
of these componentsafterfusion withlysosomes.Understress
conditions, such as growth factor deprivation, autophagy
increases in order to provide the nutrients needed for
metabolism. Autophagy is tightly regulated by a group of
evolutionarily conserved genes, the atg (autophagy-related)
genes.
1 A key protein in autophagy signaling is Bcl-2-
interacting protein-1 (Beclin-1), the mammalian homolog of
yeast Atg6.
2 Beclin-1 functions as a platform by binding
to phosphatidylinositol-3-kinase class-3 (PI3KC3)/vacuolar
protein sorting-34 (Vps34), UV-resistance-associated gene
(UVRAG),AMBRA-1(activatingmoleculeinBeclin-1-regulated
autophagy) and/or Barkor (Beclin-1-associated autophagy-
related key regulator) to assemble the PI3KC3 complex during
initiation of autophagosome formation.
3–7 The autophagic
response of embryonic stem (ES) cells deﬁcient in Beclin-1 is
severelyaltered.AbsenceofbothBeclin-1 alleles inmiceleads
to embryonic death, demonstrating the importance of auto-
phagy in the maintenance of tissue homeostasis.
8,9
Cellular stress may also result in cell death. Apoptosis, as a
prototype of cell death, is induced either via the extrinsic
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pathway when mitochondrial pro-death factors, such as
cytochrome c (cyt c) and HtrA2 (high-temperature require-
ment protein-A2)/Omi, are released.
10 Apoptotic signaling
leads to activation of caspases (casps),
11–13 which speciﬁ-
cally cleave native proteome substrates after aspartate
residues, resulting in delocalization of proteins, loss or gain
of function, or loss of complex formation.
14 Cleavage of these
substrates during apoptosis leads to the typical biochemical
and morphological characteristics, such as chromatin con-
densation,DNAfragmentation,cellshrinkage,andmembrane
blebbing.
15,16 While apoptosis is clearly a primary cell death
mechanism, there is much controversy about the functional
role of autophagy in life and death.
17,18 Depending on the
cellular context, the cell line and the stimulus, autophagy
either favors or counteracts cell death signaling.
19–21 It is
believed that multiple connections exist between autophagy
and apoptosis, and so the molecular interplay and functional
relationship between their pathways have gained consider-
able interest.
22–24
Beclin-1 was recently identiﬁed as a novel Bcl-2 homology
domain-3 (BH3)-only member of the B-cell lymphoma-2 (Bcl-
2) family; it possesses a Bcl-2 homology-3 (BH3) domain that
mediates its interaction with the antiapoptotic proteins Bcl-2
and Bcl-xL (B-cell lymphoma extra long).
25–27 Binding of
Beclin-1 to Bcl-2 or Bcl-xL inhibits the autophagic function of
Beclin-1,
26,28 suggesting that Beclin-1 might have a role in the
convergence between autophagy and apoptotic cell death. In
thisstudyweaimedtoinvestigatethecrosstalkbetweenthese
pathways and explore the fate of the autophagy proteins
Beclin-1 and PI3KC3 during apoptosis. We used a cellular
model system in which growth factor deprivation induces
autophagy followed by apoptotic cell death. Our data clearly
demonstrate the interplay between autophagy and apoptosis,
as casp-mediated cleavage not only abrogates the auto-
phagic function of Beclin-1, but also generates a Beclin-1-C
fragment that can enhance the apoptotic pathway. By using
puriﬁed Beclin-1-C fragments we showed that Beclin-1-C can
release cyt c and HtrA2/Omi from mitochondria.
Results
Autophagy precedes apoptosis induced by withdrawal
of IL-3 from Ba/F3 cells. Withdrawal of growth factors
triggers the autophagic pathway in many different cell
types.
29 Ba/F3 is a murine hematopoietic cell line that is
dependent on interleukin-3 (IL-3) for its growth.
30 We
monitored autophagy in these cells upon IL-3 deprivation,
using processing of cytosolic microtubule-associated protein
light chain-3 (LC3)-I into LC3-II as an autophagy-speciﬁc
marker.
31,32 Consistent with a recent report,
33 IL-3
deprivation was associated with increased autophagy
during the ﬁrst 8h, as evidenced by increased LC3-II levels
(Figure 1a). Note that basal levels of LC3-II could be
Figure 1 Autophagy precedes apoptosis induced in Ba/F3 cells by IL-3 withdrawal. (a) Ba/F3 WT cells were deprived of IL-3 for the indicated durations. Protein samples
were prepared and analyzed by western blotting using anti-LC3 and anti-tubulin antibodies. TEM images of autophagic vacuoles in Ba/F3 cells depleted of IL-3 for 6h. (b)A t
several time points after IL-3 deprivation of Ba/F3 cells, cellular extracts were prepared and analyzed by immunoblotting with anti-LC3, anti-caspase-3 and anti-tubulin
antibodies. (c) Ba/F3 cells were incubated in complete medium (control) or medium lacking IL-3, and examined microscopically after 24h. Dying cells were visualizedb y
uptake of PI.Note thecondensednuclei.(d)Six hoursafter IL-3depletion,the mediumwas left untouchedor was re-supplemented with IL-3.PI-positivecellswere measured
by ﬂow cytometry at 0, 6 and 24h
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Cell Death and Diseasedetected even in the presence of IL-3 (0-h time point in
Figure 1a), which reﬂects regulation of cellular homeostasis
by autophagy. Transmission electron microscopy (TEM)
analysis of Ba/F3 cells deprived of IL-3 for 6h conﬁrmed
the presence of autophagosomes, recognized as double
membrane-bound vacuoles engulﬁng cytosolic contents or
organelles (Figure 1a). Sustained IL-3 deprivation induces
the apoptotic mitochondrial pathway
30,34 followed by
activation of executioner casps about 6 to 8h post-
treatment, as monitored by detecting processed casp-3 on
western blot (Figure 1b). The plasma membrane eventually
lost its integrity (Figure 1c). Interestingly, restitution of IL-3
after 6h of depletion rescued the cells from death, as
assessed by propidium iodide (PI) exclusion (Figure 1d). This
indicates that activation of autophagy per se does not result
in cell death in these cells. Notably, reduced levels of LC3-II
were observed 10h after growth factor deprivation
(Figure 1a), indicating that autophagy levels are diminished
once casp-3 is activated. Together, these data demonstrate
that growth factor depletion of Ba/F3 cells induces autophagy
as a pro-survival mechanism, but apoptotic cell death follows
if deprivation is sustained.
Beclin-1 and PI3KC3 are cleaved during apoptosis. As
autophagy precedes apoptosis induced by IL-3 withdrawal,
we used this cellular model system to study the fate of the
autophagy proteins Beclin-1 and PI3KC3. We observed that
Beclin-1 and PI3KC3 are cleaved in Ba/F3 cells deprived
of IL-3 (Figure 2a). After 12 to 16h of IL-3 deprivation, full-
length Beclin-1 (Beclin-1-FL) was cleaved into three major
fragments of 50, 37 and 35kDa, which accumulated with
time. For PI3KC3 (105kDa) two cleavage fragments of about
50kDa were detected (Figure 2a). Proteolysis of Beclin-1
and PI3KC3 coincided with casp-3 maturation and cleavage
of poly-ADP (adenosine diphosphate)-ribose polymerase
(PARP) (Figure 2a).
Apoptosis-associated cleavage of Beclin-1 and PI3KC3 is
not restricted to IL-3 deprivation of Ba/F3 cells, since we also
observed cleavage using other cell lines and/or proapoptotic
triggers. In both murine (Ba/F3, FDCP1) and human (U937)
cell lines, Beclin-1 and PI3KC3 are cleaved during apoptosis
induced by growth factor or serum deprivation (Figure 2b
and c). In addition, doxorubicin, etoposide and anti-Fas
treatment of Ba/F3 cells elicited a similar Beclin-1 cleavage
pattern (Figure 2d and e), indicating that this event occurs
independently of the cell type and the apoptotic trigger.
Beclin-1 and PI3KC3 cleavage during apoptosis is
mediated by casps. Casps are the main proteases
activated during apoptotic signaling.
12 As cleavage of
Beclin-1 and PI3KC3 occurred simultaneously with casp
activation, we investigated whether these proteins are
targets of casp-mediated proteolysis. Blocking casp
activity with carbobenzoxy-valyl-analyl-aspartyl-[O-methyl]-
ﬂuoromethylketone (zVAD-fmk) prevented the processing of
PI3KC3, which points to the involvement of casps in its
cleavage (Figure 3a). Pretreatment of Ba/F3 cells with
zVAD-fmk also prevented the generation of the 37 and 35-
kDa Beclin-1 fragments (Figure 3b). In contrast, the 50-kDa
fragment was still detected by western blotting, indicating
that it is generated by another protease. To explore whether
these components of the autophagy-inducing complex are
direct casp substrates, in vitro-translated Beclin-1 and
PI3KC3 were incubated with active recombinant casps.
Upon incubation with recombinant casp-3, 7 and 8, PI3KC3
was cleaved into 50- and 48-kDa fragments (Figure 3c).
Casp-3, 7 and 8 also directly cleaved Beclin-1 into fragments
of 37 and/or 35kDa similar to those detected in apoptotic
cells (Figure 3d). In silico analysis of the Beclin-1 protein
sequence revealed several classical casp recognition sites:
of these, cleavage after TDVD
133 and DQLD
149 would
generate fragments of 37 and 35kDa.
35 These potential
cleavage sites, which lie immediately downstream from the
BH3 domain, are completely conserved between mouse and
human Beclin-1 (Figure 3e). Substitution of D
133 and D
149
completely abrogated the cleavage of Beclin-1 by casp-3 and
8 (Figure 3f). Substitution of D
149 abrogated the generation of
the 35-kDa fragment only, indicating that two cleavage sites
are involved (Supplementary Figure 1). Therefore, we
conclude that the 35- and 37-kDa Beclin-1 fragments
generated during apoptosis are C-terminal Beclin-1
fragments resulting from casp-mediated cleavage at D
149
and D
133, respectively.
Casp-mediated Beclin-1 fragments cannot induce
autophagy. Next, we investigated whether casp-mediated
cleavage of Beclin-1 affects its autophagy-inducing function.
Based on the identiﬁcation of the casp-cleavage sites, we
Figure 2 Beclin-1 and PI3KC3 are cleaved during apoptosis. (a) Whole-cell
lysates were prepared from Ba/F3 cells deprived of IL-3 for 0, 8, 12, 16, 20, 24 or
30handanalyzedbywesternblottingwithanti-Beclin-1,anti-PI3KC3,anti-caspase-
3 and anti-PARP antibodies. (b) Anti-Beclin-1 and (c) anti-PI3KC3 immunoblot
analysis of IL-3-deprived FDCP1 cells and serum-starved U937 cells. (d and e)
Western blot analysis showing Beclin-1 cleavage after treatment of Ba/F3 cells with
etoposide and doxorubicin (d) or anti-Fas (±CHX) (e). Eto, etoposide; doxo,
doxorubicin; CHX, cycloheximide
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Cell Death and Diseasegenerated expression vectors to express Beclin-1-FL, Beclin-
1-N (aa 1–133) and Beclin-1-C (aa 150–450). These vectors
were transfected separately into HeLa cells but together with
GFP-LC3. Expression of the Beclin-1 constructs was
conﬁrmed by western blotting (Figure 4a), and induction of
autophagy was measured by microscopic monitoring of GFP-
LC3 dots (Figure 4b–f). Overexpression of Beclin-1-FL
resulted in about threefold increase in GFP-LC3 dots in
comparison with the control cells (Figure 4b, c and g). No
increase in autophagic activity was observed after
transfection of Beclin-1-N and/or Beclin-1-C, indicating that
the caspase-mediated cleavage fragments of Beclin-1
cannot activate the autophagic pathway (Figure 4b, d, e
and g).
Beclin-1-C localizes to the mitochondria. To investigate
whether casp-mediated Beclin-1 processing altered its
subcellular localization, we performed subcellular
fractionation of Ba/F3 cells deprived of IL-3. Western blot
analysis illustrates that the 37 and 35-kDa fragments
accumulated only in the fraction enriched for mitochondria,
as determined by detection of Cox-IV (mitochondrial marker)
and p44/42 (cytosolic marker) (Figure 5a). Beclin-1-FL was
also detected in the mitochondrial fraction, although this
fraction contained some cytosolic contamination as shown by
detection of p44/42. To further characterize the subcellular
localization of Beclin-1-C, we performed immuno-
cytochemistry on HeLa cells expressing Beclin-1-FL,
Beclin-1-N or Beclin-1-C. While Beclin-1-FL staining was
predominantly cytosolic and to a minor extent mitochondrial,
all Beclin-1-N accumulated in the nucleus and Beclin-1-C
localized at the mitochondria (Figure 5b). These
observations were conﬁrmed by line proﬁles of relative
ﬂuorescence intensities showing almost complete overlap
between Beclin-1-C (green) and MitoTracker Red, and
between Beclin-1-N (green) and the nucleus (blue)
(Figure 5c). There was nearly no overlap between Beclin-1-
FL and MitoTracker Red or the nucleus. Our combined data
demonstrate intracellular redistribution of Beclin-1 upon
caspase cleavage, resulting in nuclear localization of
Beclin-1-N and accumulation of Beclin-1-C at the
mitochondria.
Beclin-1-C sensitizes Ba/F3 cells to apoptosis induced
by IL-3 deprivation. To study the functional consequence
of the generation of Beclin-1-C during apoptosis induced by
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Figure 3 Cleavageof Beclin-1 and PI3KC3 is mediatedby caspases. (a, b) IL-3-deprived Ba/F3 cells were cultured in the absenceor presence of 25mM of zVAD-fmk for
0, 16 or 20h. Cell lysates were prepared and western blotting was performed with anti-PI3KC3 antibody (a) or anti-Beclin-1 antibody (b). (c) PI3KC3 and (d) Beclin-1 were
transcribed and translated in vitro in the presence of
35S-methionine and then left untreated or incubated with 300nM of recombinant casp-3, 7 or 8. The cleavage fragments
wereanalyzedbySDS–PAGEand autoradiography. (e)A schemerepresentingBeclin-1.Sequencealignmentof murineand humanBeclin-1 showsconservationof thecasp
cleavagesites,TDVDandDQLD.Thecasp-dependentcleavagesitesareindicatedinbold.Thenuclearexportsignal(NES),BH3,coiled-coildomain(CCD)andevolutionarily
conserved domain (ECD) are depicted. (f) Autoradiography of
35S-labeled Beclin-1 (WT) and Beclin-1-D
149A/D
133A mutant (M), which were left untreated or were incubated
with 300nM recombinant casp-3 or 8
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Cell Death and DiseaseIL-3 withdrawal, we generated Ba/F3 stable cell lines
expressing Beclin-1-FL (FL-1, FL-2, FL-3) or Beclin-1-C
(C-1, C-2, C-3). Stable GFP-expressing Ba/F3 cells served
as negative control. All cell lines were incubated in IL-3-
depleted growth medium and cell death was monitored.
Upon IL-3 depletion, Ba/F3 clones expressing Beclin-1-FL
were unaffected (Figure 6a), but clones expressing
Beclin-1-C showed up to 45% enhancement of the
apoptotic response (Figure 6a). This sensitization was
dose-dependent, as enhancement of apoptosis correlated
with the levels of Beclin-1-C expression.
Beclin-1-C induces the release of cyt c from isolated
mitochondria. The previous observations that Beclin-1-C
translocates to the mitochondria upon IL-3 withdrawal and
sensitizes to IL-3 deprivation-induced apoptosis, prompted
us to investigate whether it can induce the release of
proapoptotic factors from mitochondria. We ﬁrst expressed
Beclin-1-FL, Beclin-1-N and Beclin-1-C in Escherichia coli
and puriﬁed the recombinant proteins as described in the
experimental section (Supplementary Figure 2). Next, the
recombinant preparations were incubated with isolated
mitochondria from liver and the supernatant was analyzed
for the presence of cyt c and HtrA2/Omi by immunoblotting.
tBid-induced release of cyt c and HtrA2/Omi served as
positive control (Figure 6b).
36 Remarkably, addition of
nanomolar amounts of recombinant Beclin-1-C to isolated
mitochondria induced the release of cyt c and HtrA2/Omi,
(Figure 6c). Small amounts of cyt c and HtrA2/Omi were
released from mitochondria upon incubation with
recombinant Beclin-1-FL. However, as Beclin-1-FL localizes
predominantly in the cytosol (Figure 5) and has no sensitizing
effect on apoptosis (Figure 6a), Beclin-1-FL probably does
not engage the mitochondrial cell death pathway. To
conclude, our data suggest that casp-mediated cleavage of
Beclin-1 results in the localization of Beclin-1-C fragments at
the mitochondria, sensitizing to apoptosis by enhancing the
release of mitochondrial pro-death factors.
Discussion
Cells of the bone-marrow-derived pro-B-cell line Ba/F3 die
apoptotically upon IL-3 withdrawal.
30,37 In line with a recent
report,
33 we show induction of autophagy soon after IL-3
withdrawal and before the propagation of apoptosis. Stress-
induced autophagy is a mechanism that, depending on cell
type and stimulus, either promotes or counteracts cell
death.
22 Under conditions of growth factor starvation, when
cellular self-maintenance is impeded, autophagy breaks
down unnecessary proteins and damaged organelles to
recycle metabolites to keep mitochondrial ATP production
and maintain viability of the cells; here autophagy plays a pro-
survival role.
21,38 Also in Ba/F3 cells, restoration of IL-3 after
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Figure 4 Casp-mediated Beclin-1 cleavage inactivates its autophagic function.
(a–f) HeLa cells were transfected with GFP-LC3 in combination with Beclin-1-FL,
Beclin-1-N, Beclin-1-C or Beclin-1-N and Beclin-1-C. (a) Western blot showing
expressionofE-taggedBeclin-1-FL,Beclin-1-NandBeclin-1-C.ABeclin-1fragment
corresponding in size to Beclin-1-N could be detected in the Beclin-1-FL setup and
isindicatedbyanasterisk.Thisfragmentisprobablyduetobackgroundlevelsofcell
death caused by the transfection process. (b–f) 24h after transfection, cells were
ﬁxed and analyzed by confocal microscopy to detect GFP-LC3 dots. (g) The
presence of GFP-LC3 dots was scored in 25 to 50 cells. The average number of
GFP-LC3 dots per cell is shown, with error bars indicating S.E.M. The number of
GFP-LC3 dots in cells expressing Beclin-1-FL was signiﬁcantly more than that in all
other samples (P-value o0.001)
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Cell Death and Disease6h of deprivation prevented the cells from dying by apoptosis.
At the time ofIL-3 re-addition, autophagy was clearlyongoing,
which implies that induction of autophagy in these cells does
not necessarily lead to cell death but acts as a pro-survival
mechanism. We used this cellular model system to further
investigate the possible link between autophagy and apopto-
sis. The apoptotic phase is characterized by the cleavage of
two key components of the autophagy-inducing PI3KC3
complex, Beclin-1 and PI3KC3. It was recently suggested
that Beclin-1 is cleaved by casps because zVAD-fmk could
reverse the decline in Beclin-1 expression levels during tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL)-
induced apoptosis in HeLa cells.
39 Moreover, D
149 was
reported as a casp cleavage site in Beclin-1.
40 We report
two casp cleavage sites downstream from the BH3 domain
(aa 108–127) at D
133 and D
149, which explains the generation
of the 37 and 35-kDa C-terminal fragments during apoptosis.
Besides these fragments, a Beclin-1 fragment of 50kDa was
detected upon induction of apoptosis in Ba/F3 cells, although
this cleavage could not be attributed to casp-mediated
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Figure 5 Delocalization of casp-mediated Beclin-1 fragments. (a) Ba/F3 cells were depleted of IL-3 for 16h and subjected to subcellular fractionation. The cytosolic and
mitochondrial fractions were analyzed by western blotting using anti-Beclin-1, anti-p44/42 and anti-Cox-IV antibodies. (b) Confocal microscopy images of HeLa cells
expressing E-tagged Beclin-1-FL, Beclin-1-N or Beclin-1-C. Beclin-1 proteins were labeled with green-ﬂuorescent Alexa Fluor-488, mitochondria were visualized with
MitoTracker Red CMXRos and nuclei with DAPI (blue). An overlay is presented in the ‘Merge’ panel. (c) Detailed colocalization of MitoTracker (red) and DAPI (blue) with
Beclin-1-FL, Beclin-1-C and Beclin-1-N (green), shown by a line proﬁle of relative ﬂuorescence intensities
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Cell Death and Diseaseproteolysis. Calpains might be responsible because a
similar 50-kDa fragment could be generated by recombinant
m-calpain from in vitro-translated Beclin-1 (Supplementary
Figure 3). Interestingly, it is known that during apoptosis
calpains are involved in the cleavage of another Atg protein,
Atg5, which functions downstream from Beclin-1 during the
formation of autophagosomes.
38,41–43
Once apoptosis is initiated in IL-3-deprived Ba/F3 cells and
casps are active, LC3-II levels are severely diminished. Here,
we demonstrate that Beclin-1 cleavage can contribute to
inhibition of autophagy during apoptosis. In contrast to Beclin-
1-FL, neither Beclin-1-N nor Beclin-1-C could activate
autophagy.
40 In addition, we demonstrate delocalization of
both Beclin-1 fragments. Beclin-1-N localized predominantly
at the nucleus, which may be explained by the loss of
the N-terminal nuclear export signal (aa 180–189) after
cleavage.
44 Beclin-1-C accumulatedat the mitochondria. This
is rather paradoxical because the BH3 domain (aa 107–135)
mediating the binding with Bcl-2 and Bcl-xL is removed from
the C-terminal part by casp cleavage.
26,27 Mounting evidence
demonstrates cleavage of several crucial autophagy-related
proteins during apoptosis, including Atg5, Atg4D, PI3KC3 and
Beclin-1.
43,45 These processing events probably lead to a
general demolition of the autophagy machinery. Besides
observing inactivation of the autophagic activity of Beclin-1-
FL, we also observed strong sensitization to apoptosis
induced by growth factor deprivation in cells expressing
Beclin-1-C. This sensitization was not evident when Beclin-1-
FL was overexpressed, which is in line with a recent report
demonstrating that overexpression of Beclin-1 does not affect
apoptosis.
46 Moreover, it has been reported that Beclin-1
deﬁciency in ES cells does not result in any change in the
apoptotic process induced by UV irradiation.
8
To shed light on how Beclin-1-C accelerates apoptosis, we
studied the effect of recombinant Beclin-1-C on the integrity of
mitochondria. We found that Beclin-1-C triggered the mito-
chondria to release proapoptotic factors such as HtrA2/Omi
and cyt c. In view of the BH3-mediated binding of Beclin-1
to Bcl-2/Bcl-xL
26,27,47,48 it is conceivable that this interaction
sequesters Beclin-1-FL from a proapoptotic function in cells.
Casp-dependent cleavage generates a BH3-free Beclin-1-C
fragment that can perform its proapoptotic function by
triggering cyt c release. Our combined results demonstrate
that caspase-mediated cleavage of Beclin-1 establishes the
crosstalk between autophagy and apoptosis. Cleavage of
Beclin-1 during apoptosis not only inactivates its autophagic
function, but also generates a Beclin-1-derived fragment that
translocates to the mitochondria and sensitizes cells to IL-3
deprivation-induced apoptosis, probably by enhancing the
release of HtrA2/Omi and cyt c (Figure 7). A similar
observation has been reported for Atg5: calpain-mediated
cleavage of Atg5 results in a truncated protein that can induce
apoptosis by interacting with Bcl-xL at the mitochondria.
43
Since the BH3 domain is not present in Beclin-1-C, the
mechanism by which Beclin-1-C triggers the release of pro-
death factors is still under investigation. In contrast to Atg5,
43
expression of Beclin-1-C is not sufﬁcient to induce cell death.
Only when cells are depleted of IL-3 does the proapoptotic
effect of Beclin-1-C become obvious. Therefore, it will also be
worthwhile to investigate which proteins are involved in
targeting Beclin-1-C to the mitochondria, and to explore the
mechanism by which Beclin-1-C triggers the mitochondria to
release proapoptotic factors. Most probably, other autophagy-
related proteins are subjected to cleavage after induction of
cell death and function synergistically to enhance the
apoptotic response. Further investigation of these cleavage
events will be important for gaining greater knowledge of the
interrelationship between autophagy and apoptosis.
Materials and Methods
Plasmids. The cDNA encoding human Beclin-1 was ampliﬁed by reverse
transcription PCR from a HeLa cDNA library using primers 50-ATA
AGAATGCGGCCGCTATGGAAGGGTCTAAGACGTCCAACAAC-30 and 50-TGC
GGTCGACTCATTTGTTATAAAATTGTGAGGACACC-30. The ampliﬁed product
was cloned in the pCAGGS-E vector in frame with the N-terminal E-tag. cDNA
encoding Beclin-1-N (aa 1–133) and Beclin-1-C (aa 150–450) were cloned similarly
using the following primers: Beclin-1-N forward: 50-ATAAGAATGCGGCCG
CTATGGAAGGGTCTAAGACGTCCAACAAC-30 and Beclin-1-N reverse: 50-TA
CGCGTCGACTCAATCCACATCTGTCTGGCCCGACAT-30; Beclin-1-C forward:
E-Beclin-1-C E-Beclin-1-FL
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Figure 6 Beclin-1-C enhances apoptosis and induces cyt c release from
isolatedmitochondria.(a)Ba/F3celllinesstablyexpressingGFP(control),E-tagged
Beclin-1-FL (FL-1, FL-2, FL-3) or Beclin-1-C (C-1, C-2, C-3) were cultured in the
absence of IL-3 for 16h and the percentage of PI-positive cells was determined by
ﬂow cytometry. Beclin-1-FL and Beclin-1-C expression levels were analyzed by
western blotting using anti-E tag antibody. Results are representative of three
independent experiments. (b–c) Mitochondria were isolated from murine livers and
incubated with the indicated concentrations of recombinant tBid (b), Beclin-1-FL,
Beclin-1-N or Beclin-1-C (c). The post-mitochondrial supernatant was analyzed by
western blotting using anti-cyt c and anti-HtrA2/Omi
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Cell Death and Disease50-ATAAGAATGCGGCCGCAATGACTCAAGCTCA-30 and Beclin-1-C reverse:
50- TGCGGTCGACTCATTTGTTATAAAATTGTGAGGACACC-30. pEF6-Beclin-1-
myc-His, used for TNT, was constructed by inserting a KpnI–NotI fragment
containing human Beclin-1 without a termination codon between the KpnI and NotI
sites of pEF6-myc-His. The cDNA encoding the Beclin-1-D
133A-D
149A mutant was
constructed by site-directed PCR mutagenesis using the following primers: D
133A-
forward: 50-ATGTCGGGCCAGACAGATGTGGCTCACCCACT-30 and D
133A-
reverse: 50-AGTGGGTGAGCCACATCTGTCTGGCCCGACAT-30;D
149A-forward:
50-ACTCTTTTAGACCAGCTGGCCACTCAGCTC-30 and D
149A-reverse: 50-
GAGCTGAGTGGCCAGCTGGTCTAAAAGAGT-30. The products were cloned in
the pEF6-myc-His vector. Proper construction of all the plasmids was conﬁrmed by
DNA sequencing.
Cell culture. The IL-3-dependent mouse pro-B-cell line Ba/F3 was maintained
in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10%
(v/v) heat-inactivated fetal calf serum, penicillin (100U/ml), streptomycin (100mg/
ml)and10%(v/v)conditionedmediumfromWEHI-3BcellsasasourceofmouseIL-
3. Cells were incubated at 371C in a humidiﬁed atmosphere containing 5% CO2.
Similar growth conditions were used for culturing the IL-3-dependent FDCP1 cells.
Ba/F3cells werestablytransfectedbyelectroporationasdescribed.
49 HumanU937
cells were maintained in RPMI 1640 medium (Invitrogen) supplemented with 10%
(v/v) heat-inactivated fetal calf serum, penicillin (100U/ml) and streptomycin
(100mg/ml).HeLacellsweregrowninDMEMmediumsupplementedwith10%(v/v)
heat-inactivated fetal calf serum, L-glutamine (2mM), penicillin (100U/ml),
streptomycin (100mg/ml) and sodium pyruvate (400mM).
Etoposide (Alexis Biochemicals, San Diego, CA, USA) and doxorubicin (Sigma,
St. Louis, MO, USA) were administered to Ba/F3 cells at concentrations of 10 or
40mM, and 1 or 10mM, respectively, for 16h. Anti-Fas (anti-mouse Fas, CD95,
clone Jo2; Pharmingen, San Diego, CA, USA) was coated on six-well plates at
10mg/ml in PBS for 24h at 41C. The wells were washed with RPMI before adding
cells. The Ba/F3 cells were seeded at 300000 cells per well in uncoated and anti-
Fas coated wells. Untreated cells, cells treated with cycloheximide (CHX) (0.2mg/
ml) or CHXþanti-Fas were lysed after 24h.
Immunoblot analysis. Cells were washed twice in ice-cold PBS and lysed in
ice-cold caspase lysis buffer (0.05% Nonidet-P40, 220mM mannitol, 68mM
sucrose, 2mM NaCl, 2.5mM KH2PO4, 10mM HEPES (pH 7.4), supplemented with
0.1mM PMSF, 200U/ml aprotinin, 10mg/ml leupeptin and 1mM oxidized
glutathione) or directly in protein loading buffer (125mM Tris–HCl (pH 6.8), 6%
SDS, 1.4M b-mercaptoethanol, 20% glycerol, 0.01% bromophenol blue). Samples
were boiled for 10min before loading. Lysates were separated in SDS–PAGE gels
of different percentages and transferred to nitrocellulose membranes by semi-dry
blotting in a buffer containing 25mM Tris–HCl (pH 8.0), 190mM glycine and 20%
methanol.Allfurtherincubationswereperformedatroomtemperatureonaplatform
shaker. Blocking, incubation with antibody and washing of the membrane were all
performed in PBS supplemented with 0.02% Tween-20 (v/v) and 3% (w/v) non-fat
dry milk. The primary antibodies used were anti-LC3 (mAb LC3-5F10; Nanotools,
Teningen, Germany), anti-Beclin-1 (BD Biosciences, San Diego, CA, USA), anti-
PI3KC3 (Zymed laboratories, South San Fransisco, CA, USA), anti-b-tubulin-HRP
(Abcam, Cambridge, UK), anti-E-HRP (Amersham Biosciences, Buckinghamshire,
UK), anti-caspase-3 (Labaratoire d’Hormonologie Animale, Marloie, Belgium), anti-
PARP (Biomol, Plymouth Meeting, PA, USA), anti-Flag-horseradish peroxidase
(HRP) (Sigma) and anti-cyt c (BD Biosciences). The anti-HtrA2/Omi antibody was
prepared as described previously.
50 Membranes were incubated with HRP-
conjugated secondary antibodies against mouse and rabbit immunoglobulin
(Amersham Biosciences). Immunoreactive proteins were visualized by enhanced
chemiluminescence (PerkinElmer, Boston, MA, USA).
Apoptosis assays. Before induction of apoptosis, Ba/F3 cells were
resuspended in fresh medium at 3 10
5cells/ml. The next day, apoptosis was
induced by IL-3 depletion for different periods of time. Loss of cell membrane
integrity as a measure for cell death was determined by monitoring PI (30mM)
uptake at 610nm by FACS analysis using a FACScalibur ﬂow cytometer (Becton
Dickinson, Sunnyvale, CA, USA) equipped with a 488-nm Argon laser.
In vitro transcription/translation. Recombinant casp-3, 7 and 8 were
generated as described.
51 The plasmids pEF6-Beclin-1-myc-His and pEF6-Beclin-
1-D133A/D149A-myc-His were used as a template for in vitro coupled transcription/
translation in a rabbit reticulocyte lysate system according to the manufacturer’s
instructions (Promega, Madison, WI, USA). For detection of the translation
products,
35S-methionine was added to the translation reactions. Translation
reactions (2ml each) were incubated with 300nM recombinant casp-3, 7 or 8 in
24ml of cell-free system buffer (10mM HEPES–NaOH (pH 7.4), 220mM
mannitol, 68mM sucrose, 2mM NaCl, 2.5mM KH2PO4, 0.5mM EGTA, 2mM
MgCl2, 5mM pyruvate, 0.1mM PMSF, 200U/ml aprotinin, 10mg/ml leupeptin)
for 1h at 371C. The cleavage products were analyzed by SDS–PAGE and
autoradiography.
Subcellular fractionation. Ba/F3 cells were harvested and washed
three times with buffer-A (20mM MOPS, 1mg/ml bovine serum albumin, 1mM
EGTA, 100mM sucrose) and resuspended in buffer-B (buffer-A plus 100mg/ml
digitonin, 0.1mM PMSF, 200U/ml aprotinin, 10mg/ml leupeptin, 1mM sodium
orthovanadate, 1mM sodium ﬂuoride). After homogenization with a dounce
homogenizer B pestle, samples were centrifuged twice (2500g, 5min, 41C) to
remove nuclei and centrifuged again (10000 g, 10min, 41C) to obtain the heavy
membrane pellet.The supernatantwas centrifugedonce more (20000 g, 10min,
41C) and the soluble part was kept as the cytosol fraction. The heavy membrane
pelletwasresuspendedin2mlof15%Percoll(v/v)andloadedonaPercollgradient
(60–40–23%). After centrifugation (32000 g, 5min, 41C), the mitochondrial
fraction was isolated. Protein samples of the different subcellular fractions were
analyzed by western blotting.
Immunocytochemistry. A total of 2 10
5 HeLa cells were grown on glass
coverslips in six-well plates (Becton Dickinson, Franklin Lakes, NJ, USA) and
transfected with 300ng E-tagged Beclin-1-FL, Beclin-1-C or Beclin-1-N using
Fugene 6 Transfection Reagent (Roche Diagnostics, Vilvoorde, Belgium). After
24h, cells were incubated for 15min at 371C with MitoTracker Red CMXRos
(MolecularProbes,Eugene,OR,USA),rinsedbrieﬂywithice-coldPBSandﬁxedfor
15min with 3% paraformaldehyde in PBS at 41C. The cells were rinsed and
permeabilizedusing0.3%saponin.Subsequently,cellswerekeptfor 30min inPBS
with 0.1% saponin and 0.5% BSA. Anti-E-tag antibody dissolved in PBS with 0.1%
saponin, 0.1% BSA and 2% gelatin was incubated for 1h at room temperature. The
secondary antibody used was Alexa-488-coupled anti-mouse immunoglobulin
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Figure 7 Proposed model of Beclin-1 cleavage in IL-3-deprived Ba/F3 cells.
Induction of apoptosis results in casp-mediated cleavage of Beclin-1. Beclin-1
cleavage inactivates its autophagic function and induces delocalization of
Beclin-1-C to the mitochondria. At the mitochondria, Beclin-1-C accelerates
apoptosis, probably by enhancing the release of cyt c and HtrA2/Omi
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Cell Death and Diseaseantibody (Molecular Probes). Finally, cells were treated with Vectashield mounting
medium containing 40,6-diamidino-2-phenylindole (DAPI) (Vectorlabs, Burlingame,
CA,USA). Forﬂuorescenceimaging,a LeicaSP5 AOBSconfocal microscope(DMI
6000) with an HCX PL APO 63.0 1.40 OIL UV objective was used.
Three sequential scans were performed. First, the 405-nm UV diode laser was
used for the DAPI signal, with an emission band 410–485nm. Next, Alexa-488 was
excited by the 488-nm argon laser and detected at 555nm to 625nm. Finally, the
543nm HeNe-laser was used for excitation of Alexa-594 with emission bandwidths
set to 570–693nm. Images were acquired at a resolution of 512 512 pixels and a
pixel size of 142nm, with six-line-averaging and a pinhole set on 1 Airy Unit. A line
proﬁle was generated by measuring ﬂuorescence intensities using AxioVision.
Counting GFP-LC3 dots. A total of 2 10
5 HeLa cells were grown on glass
coverslips in six-well plates (Becton Dickinson) and transfected with 250ng GFP-
LC3 and 300ng E-tagged Beclin-1-FL, Beclin-1-C or Beclin-1-N using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). The medium was refreshed
6h after transfection. After 24h, the cells were incubated for 30min at 371C with
100nM baﬁlomycin (Sigma Aldrich). The cells were rinsed with PBS, ﬁxed with 1%
paraformaldehyde at 41C for 15min, incubated with Draq5 (Alexis Biochemicals,
San Diego, CA, USA) diluted 1:1000 in PBS for 15min and treated with FluorSave
(Calbiochem,SanDiego,CA,USA).Foreachtransfectionweanalyzed25–50cells.
P-value was determined by ANOVA and post hoc statistical analysis.
Transmission electron microscopy. Cells were ﬁxed in 4%
paraformaldehyde and 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer
(pH 7.2) for 4h at room temperature and then ﬁxed overnight at 41C. After washing
inbuffer,thecellswerepost-ﬁxedin1%OsO4with1.5%K3Fe(CN)6in0.1Msodium
cacodylate buffer. After washing, the cells were dehydrated through a graded
ethanol series, including bulk staining with 1% uranyl acetate at the 50% ethanol
step, and then embedded in Spurr’s resin. Ultrathin sections of a gold interference
color were cut using an ultra microtome (Ultracut E/Reichert-Jung), post-stained
withuranylacetateandleadcitratein aLeicaultrastainer,andcollectedon formvar-
coatedcopperslotgrids.Theywereviewedwithatransmissionelectronmicroscope
1010 (JEOL, Tokyo, Japan).
Expression and puriﬁcation of recombinant Beclin-1-FL, Beclin-
1-N and Beclin-1-C. cDNA encoding Beclin-1-FL, Beclin-1-N and Beclin-1-C
was ampliﬁed by using the following primers: Beclin-1-FL forward: 50-CGGGG
TACCCATGGAAGGGTCTAAGACGTCC-30 and Beclin-1-FL reverse: 50-CGGGAT
CCTCATTTGTTATAAAATTGTGAGG-30; Beclin-1-N forward: 50-CGGGGTACCC
ATGGAAGGGTCTAAGACGTCC-30 and Beclin-1-N reverse: 50-CGGGATCCTC
AATCCACATCTGTCTGGC-30; Beclin-1-C forward: 50-CGGGGTACCCATGACTC
AGCTCAACGTCACTGAAAATGAG-30 and Beclin-1-C reverse: 50-CGGGATCC
TCATTTGTTATAAAATTGTGAGG-30. After digestion with KpnI–BamHI, the
ampliﬁed products were cloned between the KpnI and BamHI sites of the
pLHX32 vector in frame with the N-terminal His6-tag and thioredoxine sequence.
All plasmids were transformed in E. coli strain MC1061 containing the transcription
regulatory plasmid pICA2 (N. Mertens, unpublished data). Cultures
growing exponentially at 281C were induced with 1.0mM isopropyl-b-D-
thiogalactopyranoside and incubated overnight at 201C. Cell pellets were
resuspended in resuspension buffer (20mM Na2HPO4.2H2O (pH 7.5), 300mM
NaCl, 0.5% (w/v) CHAPS, supplemented with 1mg/100ml DNase-I (Roche
Diagnostics, Mannheim, Germany) and complete, EDTA-free Protease Inhibitor
Cocktail Tablets (Roche Diagnostics)) and were lysed by sonication. Insoluble
proteins were removed by centrifugation. The supernatant was loaded on a Ni
2þ–
Sepharose 6FF column (GE Healthcare, Piscataway, NJ, USA) pre-equilibrated
with buffer-A (20mM Na2HPO4.2H2O (pH 7.5), 300mM NaCl, 0.5% (w/v) CHAPS)
containing20mMimidazole.Low-strength,metal-bindingproteinswereremovedby
washing with buffer-A containing 50mM imidazole. His-tagged Beclin-1 was eluted
from the column with a three-step gradient in buffer-B (20mM Na2HPO4.2H2O (pH
7.5), 20mM NaCl, 0.5% (w/v) CHAPS) containing 100, 200 or 400mM imidazole.
FractionscontainingBeclin-1-FLorBeclin-1-Cwerepooledandpuriﬁedfurtherona
Superdex 200 column (GE Healthcare, running buffer, buffer-C: 20mM Tris–HCl
(pH 7.5), 0.5% (w/v) CHAPS, 150mM NaCl). Fractions containing Beclin-1-N were
pooled and loaded on a Source 30Q column (GE Healthcare) pre-equilibrated with
buffer-D (20mM Tris–HCl (pH 7.5), 0.1% (w/v) CHAPS). Bound proteins were
elutedwithalineargradientfrom0to0.5MNaClinbuffer-D.Finally,Beclin-1-Nwas
run on a Superdex 200 column in buffer-C. The purity of the fractions was checked
by SDS–PAGE followed by Coomassie blue staining and western blot analysis
using Penta-His antibody (Qiagen, Hilden, Germany). The fractions containing
Beclin-1-FL/-N/-C were pooled and stored at  701C.
Isolation of murine liver mitochondria. C57BL/6 wild-type mice (7 to 12
weeks of age) were used. Livers were homogenized using a Wheaton type-B
douncer in homogenization buffer (5mM KH2PO4 (pH 7.4), 0.3M sucrose, 1mM
EGTA, 5mM 3-[N-morpholino]propanesulfonic acid). Intact cells and nuclei were
removed from the homogenates by centrifugation, twice at 1800 g and once at
3000 g, each time for 5min at 41C. The supernatant was spun down at
10000 g for 10min at 41C to precipitate the heavy membrane fraction containing
the mitochondria and further puriﬁed on a Percoll gradient as described earlier.
52
The mitochondrial pellet was resuspended in cell-free system buffer (10mM
HEPES–NaOH (pH 7.4), 220mM mannitol, 68mM sucrose, 2mM NaCl, 2.5mM
KH2PO4, 0.5mM EGTA, 2mM MgCl2, 5mM pyruvate, 0.1mM PMSF, 1mM
dithiothreitol) and kept on ice until used within 1h of preparation.
Cyt c release assay. Mitochondria equivalent to 40mg of liver protein were
incubatedat 371Cin 100ml cell-freesystembufferfor 20min with recombinanttBid,
Beclin-1-FL, Beclin-1-N or Beclin-1-C. Supernatants were separated from
mitochondria by centrifugation at 20000 g for 10min at 41C. One-ﬁfth of the
supernatant was analyzed by immunoblotting with anti-cyt c.
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